
The equities markets had a slightly bullish inclination today. The healthcare Tesaro, Inc. (TSRO) was up over +58% today after news hit that the company was being bought out by GlaxoSmithKline (GSK). The buyout price is $75 per share in cash, which caused GSK stock to drop over -8%. Previously in mid-November, TSRO was up strongly due to reports that the company was exploring a potential sale. However, it was not until today that this was confirmed. Here’s a recap.